Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07597395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ATRA for Management of Primary ITP

Name: ATRA for Management of Primary ITP — clinical trial record (NCT07597395)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorPeking University People's Hospital

Started2026-05-30

View on ClinicalTrials.gov ↗

Peking University People's Hospital

220 trials monitored

See 6 trials at risk

A multicenter, randomized, double-blind placebo-controlled study to report the efficacy and safety of all-trans etinoic acid compared to placebo for the treatment of adults with corticosteriod-resistant/relapsed primary immune thrombocytopenia (ITP).

Trial Details

NCT Number	NCT07597395
Lead Sponsor	Peking University People's Hospital Collaborators: Peking University First Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Peking University Third Hospital, Beijing Hospital
Conditions	Immune Thrombocytopenia
Enrollment	192 participants
Start Date	2026-05-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-19